鶹ýɫƬ

Journal News

Quantifying how proteins in microbe and host interact

Poornima Sankar
Nov. 20, 2024

Antimicrobial resistance is a growing problem around the world. When microbes such as bacteria, viruses, parasites and fungi stop responding to antimicrobial medicines, most researchers respond by working to develop new vaccines. However, when host proteins bind to bacterial proteins, that binding masks some dominant antigenic sites on the pathogen. Because of this, traditional vaccines have seen poor antibody responses. 

In a recent published in the journal 鶹ýɫƬ & Cellular Proteomics,  researchers at Lund University used affinity purification combined with quantitative mass spectrometry, or AP-MS, techniques to investigate if these bacteria and host protein–protein interaction networks could compromise the development of protective antibody responses; they used Streptococcus pyogenes, a bacteria that causes infections in humans,as a model system.

was the corresponding author of this study. “To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” he said.

Streptococcus pyogenesbelongs to Group A Streptococcus, or GAS, which affects about 18 million people annually, and claims over 500,000 lives, so an urgent need exists for a vaccine against GAS.

In , Malmström’s lab has shown that GAS forms extensive protein interaction networks with human proteins, so they wanted to analyze the association between the antigen-specific antibody responses and the host protein–bacterial protein interactions. They also wanted to understand if antigen-specific antibody responses could affect these protein networks to understand antibody repertoire (the entire set of antibodies produced in an individual), ultimately aiding the development of effective vaccines against GAS.

In this study, the researchers immunized mice with the conserved M1 protein from GAS and showed that mouse plasma protein forms similar protein networks with the bacterial M1 protein as those seen in humans. Using AP-MS, they quantified the competition among antibodies and protein interaction networks.

While the team found that the antigen targeted by the anti-M1 antibodies affected sites outside the protein interaction surfaces and could not outcompete these interactions, they also discovered in this study that regions in bacterial proteins within protein-interaction interfaces are more challenging to develop antibodies against, highlighting the need to quantify and assess these interactions.

Several bacterial pathogens use their surface proteins to interact with the host proteins to dodge the immune system and mask their dominant epitopes.

The experimental strategy developed in this study can measure the level of competition between antibodies and host plasma proteins at the same bacterial sites, thereby dictating the course of host immune responses. This method could be broadly applicable to any type of bacterial protein.

“I think that the most efficient way forward would be to build networks of scientists with different research skills and meet around the same problem,” Malmström said.

Read more about this group’s research .

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Poornima Sankar

Poornima Sankar is a graduate student at the Department of Immunology and Microbial Disease at Albany Medical Center. She is an ASBMB Today volunteer contributor.

Related articles

From the journals: JBC
Emily Ulrich
From the journals: MCP
Jessica Desamero
From the journals: MCP
Nivedita Uday Hegdekar
From the journals: JBC
Ken Farabaugh

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Elucidating how chemotherapy induces neurotoxicity
Award

Elucidating how chemotherapy induces neurotoxicity

Dec. 2, 2024

Andre Nussenzweig will receive the Bert and Natalie Vallee Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Where do we search for the fundamental stuff of life?
Essay

Where do we search for the fundamental stuff of life?

Dec. 1, 2024

Recent books by Thomas Cech and Sara Imari Walker offer two perspectives on where to look for the basic properties that define living things.

UCLA researchers engineer experimental drug for preventing heart failure after heart attacks
News

UCLA researchers engineer experimental drug for preventing heart failure after heart attacks

Nov. 30, 2024

This new single-dose therapy blocks a protein that increases inflammation and shows promise in enhancing muscle repair in preclinical models.

The decision to eat may come down to these three neurons
News

The decision to eat may come down to these three neurons

Nov. 28, 2024

The circuit that connects a hunger-signaling hormone to the jaw to stimulate chewing movements is surprisingly simple, Rockefeller University researchers have found.

Curiosity turned a dietitian into a lipid scientist
Award

Curiosity turned a dietitian into a lipid scientist

Nov. 27, 2024

Judy Storch will receive the Avanti Award in Lipids at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

From receptor research to cancer drug development: The impact of RTKs
Award

From receptor research to cancer drug development: The impact of RTKs

Nov. 26, 2024

Joseph Schlessinger will receive the ASBMB Herbert Tabor Research Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.